Jobs / United States / Astrazeneca Pharmaceuticals Lp
Global Commercial Head, Immunology
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles10 certified filings for “Scientist, Cancer Immunology, Oncology Research” (Biochemists and Biophysicists) in MD: $104k–$138k, median $130k. Most were filed at wage level II (60%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
At AstraZeneca, we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big, and working together to make the impossible a reality. We are passionate about the potential of science to address the unmet needs of patients around the world. We commit to those areas where we believe we can really change the course of medicine and bring innovative ideas to life. Respiratory & Immunology, part of AstraZeneca BioPharmaceuticals is a key disease area and growth driver to the Company. Our ambition in Immunology is to transform care for people living with chronic, complex immune-mediated diseases. With a growing portfolio and pipeline, we are advancing innovative science and building the capabilities required to deliver meaningful, lasting impact for patients worldwide. We have already made significant progress through the launch of our first medicine for systemic lupus erythematosus (SLE), and recently expanded through the launch of a subcutaneous formulation. With further Phase 3 development programs currently ongoing in Cutaneous Lupus (CLE) and Lupus Nephritis (LN) we are excited to potentially reach additional specialties & patient groups. This is an opportunity to contribute to the continued evolution of an important Immunology franchise and help deliver both near-term brand performance and long-term value. The Opportunity We are seeking an experienced Global Commercial Head, Immunology to lead all aspects of the global business strategy and execution for a major Immunology asset. Reporting to the Vice President, Global Commercial Immunology , you will shape the product strategy, maximize its value across the lifecycle and ensure strong execution in regions and markets. You will lead a team of direct reports and serve as the senior commercial voice on the global product team and lead the global brand team. What You’ll Do • Develop and evolve the global commercial strategy, brand plan and operational priorities, grounded in patient, customer and market insights. • Serve as the senior commercial voice on the global cross-functional product team and shape key development, regulatory and lifecycle decisions. • Partner with Medical Affairs, Market Access, Regulatory, Clinical Development, Insights & Analytics, Policy, Patient Advocacy, Finance, Supply and Commercial Excellence. • Translate global strategy into clear direction for regions and markets, supporting effective execution, launches and lifecycle growth. • Define positioning, priority audiences and the value proposition using robust market research, competitive intelligence and customer insight. • Ensure forecasts and business plans are grounded in product strengths, unmet need, competitive dynamics, pricing and access considerations. • Engage external experts, healthcare professionals, patient organizations and other stakeholders to bring patient and customer perspectives into strategy. • Lead strategic agency and vendor relationships and ensure effective allocation of resources. • Create an inclusive, high-performing team environment; set a clear vision, coach and develop talent, and role-model AstraZeneca values. Size of Team The Global Commercial Head will 3-5 direct reports and provide leadership across a broader global matrix. Required Experience • BA/BS in Business, Medical, Life Sciences or a related discipline. • US commercial and launch experience. • 10 years’ experience in pharmaceutical development and commercialization, including leadership of global brand strategy and execution. • Strong expertise and a current understanding of the advanced treatment landscape, customers, competitors and evolving standards of care in rheumatology or dermatology. • Demonstrated launch and lifecycle management success in a com